Hepatitis C Resources
Chosen by Advanced
Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates
Hepatitis C Resources
Chosen by Advanced
Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates

Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence

Substance use disorders affect roughly 25% of Americans aged 12 and older, with illicit drug use prevalent in 2022. The advent of direct-acting antivirals (DAAs)…

New Strategies in HCV Treatment and Vaccine Development: Advances and Challenges

Hepatitis C virus (HCV) remains a significant global health challenge, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Direct-acting...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

APOE4’s Paradoxical Role: Increased COVID-19 Severity but Protection in HCV Liver Disease

Hepatitis C virus (HCV) and COVID-19 both affect the liver and cardiovascular systems, with the APOE4 allele playing a complex...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

HCV Treatment Reduces Cardiovascular, Renal, and Ocular Risks in Patients Who are Diabetic

Researchers of this study investigated the impact of successful hepatitis C virus (HCV) treatment on long-term complications in patients with...
CURATED BY:
Gabriella McCarty,
MSN, NP-C

Physician Associate and Nurse Practitioner Contributors
to the POCN Hepatitis C Center of Excellence

POCN’s Hepatitis C Center of Excellence is curated by practicing clinical nurse practitioners and physician associates who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers, including guidelines, news, and best practices for those diagnosing and treating patients with hepatitis C.

Provided by an unrestricted grant from

Share